Immunogenicity & researc Summit 2014 (Immunogenicity Prediction & Mitigation )

The Holy Grail for the biotherapeutics industry is for products with absent or reduced immunogenicity. In this track we examine factors that may impact on immunogenicity, particularly aggregates, sub-visible particles, and host cell proteins, and report on innovative tools used by the experts to predict immunogenicity. We also examine novel approaches for deimmunization and tolerance induction. Cambridge Healthtech Institute'sSixth Annual Immunogenicity Prediction & Mitigation conference is particularly important at the early stages of development for informed decision-making on candidate selection, dosing and formulation.